Evimed
Evimed is a company dedicated to enabling faster patient access to treatments through tailored solutions in evidence generation, dossier preparation, and localisation. They focus on health economics, outcomes research, health technology assessment, pricing, and market access, supporting clients in overcoming access, reimbursement, and pricing challenges to ensure innovative medicines reach patients quickly.
Industries
Nr. of Employees
small (1-50)
Evimed
500 Terry Francine Street, 6th Floor, San Francisco, CA 94158
Products
Health Technology Assessment
Development of strategies and submissions for health technology assessments across various stages of drug development.
Health Technology Assessment
Development of strategies and submissions for health technology assessments across various stages of drug development.
Health Economic Modelling
Creation and localization of economic models for pricing, decision-making, and submission purposes.
Health Economic Modelling
Creation and localization of economic models for pricing, decision-making, and submission purposes.
Statistical Data Analysis
Conducting statistical analyses for HTA submissions, economic modelling, and publications.
Statistical Data Analysis
Conducting statistical analyses for HTA submissions, economic modelling, and publications.
Health Technology Assessment
Development of strategies and submissions for health technology assessments across various stages of drug development.
Health Technology Assessment
Development of strategies and submissions for health technology assessments across various stages of drug development.
Health Economic Modelling
Creation and localization of economic models for pricing, decision-making, and submission purposes.
Health Economic Modelling
Creation and localization of economic models for pricing, decision-making, and submission purposes.
Statistical Data Analysis
Conducting statistical analyses for HTA submissions, economic modelling, and publications.
Statistical Data Analysis
Conducting statistical analyses for HTA submissions, economic modelling, and publications.
Services
Provision of systematic, targeted and rapid literature reviews and evidence synthesis for regulatory submissions and HTA dossiers, including indirect treatment comparisons and network meta-analyses.
Development, localisation and validation of economic models for pricing, submission and decision-making, including early models, global and disease-agnostic models, budget-impact and bespoke models.
Statistical analyses to support HTA inputs and secondary publications, covering survival analysis, treatment switching, quality-of-life analyses, utility estimation and post-hoc trial analyses.
Strategic advice on HTA and reimbursement submission strategy, assessment of development programmes, risk identification and mitigation to maximise HTA acceptability.
Adaptation of reports and modelling outputs to meet local methodological guidelines and jurisdictional requirements for HTA submissions.
Introductory consultation to discuss services, capabilities and project needs.
Provision of systematic, targeted and rapid literature reviews and evidence synthesis for regulatory submissions and HTA dossiers, including indirect treatment comparisons and network meta-analyses.
Development, localisation and validation of economic models for pricing, submission and decision-making, including early models, global and disease-agnostic models, budget-impact and bespoke models.
Statistical analyses to support HTA inputs and secondary publications, covering survival analysis, treatment switching, quality-of-life analyses, utility estimation and post-hoc trial analyses.
Strategic advice on HTA and reimbursement submission strategy, assessment of development programmes, risk identification and mitigation to maximise HTA acceptability.
Adaptation of reports and modelling outputs to meet local methodological guidelines and jurisdictional requirements for HTA submissions.
Introductory consultation to discuss services, capabilities and project needs.
Expertise Areas
- Health economics and outcomes research (HEOR)
- Health technology assessment (HTA) strategy and submissions
- Evidence synthesis and systematic literature review
- Economic modelling and cost-effectiveness analysis
Key Technologies
- Network meta-analysis
- Matching-adjusted indirect comparison (MAIC)
- Multi-level network meta-regression
- Survival analysis